Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the causative
agent of the pandemic disease COVID-19, which is so far without efficacious treatment. The …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible
and virulent human-infecting coronavirus that emerged in late December 2019 in Wuhan …

We report that there is a recent global expansion of numerous independent severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with mutation L452R in the …

While the standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two
doses administered 3 weeks apart, some public health authorities are spacing these doses …

The manifestations of COVID-19 have been evolving over time. Various post-COVID-19
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …

ABSTRACT Non-structural protein 2 (nsp2) exists in all coronaviruses (CoVs), while its
primary function in viral pathogenicity, is largely unclear. One such enteric CoV, porcine …

Purpose Whole genome sequencing of SARS-CoV2 is important to find useful information
about the viral lineages, variants of interests and variants of concern. As there are not …

The standard dosing of the Pfizer/BioNTech BNT162b2 mRNA vaccine validated in clinical
trials includes two doses administered three weeks apart. While the decision by some public …

Objectives We used whole-genome sequencing of SARS-CoV-2 to identify variants
circulating in the Democratic Republic of the Congo and obtain molecular information useful …

Background: We conducted this review to summarize the relation between viral mutation
and infectivity of SARS-CoV-2 and also the severity of COVID-19 in vivo and in vitro. Method …